{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:33:43Z","timestamp":1787020423431,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27384-3","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:13:59Z","timestamp":1777000439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics, treatment patterns, and prognosis in vulvar cancer and vaginal cancer: a national multicenter retrospective study in China"],"prefix":"10.1186","volume":"26","author":[{"given":"Xuelian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiwen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaokai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"2","key":"27384_CR1","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C DE MARTEL","year":"2020","unstructured":"de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u2013e190.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"27384_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"M DE MARTEL C, PLUMMER","year":"2017","unstructured":"De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u2013670.","journal-title":"Int J Cancer"},{"key":"27384_CR3","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240014107. Accessed 23 April 2026."},{"issue":"10","key":"27384_CR4","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1002\/ijc.33055","volume":"147","author":"F BRAY","year":"2020","unstructured":"Bray F, Laversanne M, Weiderpass E, Arbyn M. Geographic and temporal variations in the incidence of vulvar and vaginal cancers. Int J Cancer. 2020;147(10):2764\u20132771.","journal-title":"Int J Cancer"},{"issue":"5","key":"27384_CR5","first-page":"702","volume":"43","author":"YUAN M W","year":"2022","unstructured":"Yuan MW, Wang HH, Duan RF, et al. [Analysis on cancer incidence and mortality attributed to human papillomavirus infection in China, 2016]. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(5):702\u20138.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"30","key":"27384_CR6","first-page":"2536","volume":"105","author":"[Expert consensus on the early prevention","year":"2025","unstructured":"[Expert consensus on the early prevention. of human papillomavirus related non-cervical diseases (2025 edition)]. Zhonghua Yi Xue Za Zhi. 2025;105(30):2536\u201350.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"27384_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1470-2045(23)00066-9","volume":"24","author":"Z LI","year":"2023","unstructured":"Li Z, Liu P, Wang Z, et al. Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2023;24(4):403\u2013414.","journal-title":"Lancet Oncol"},{"issue":"1","key":"27384_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ijc.32078","volume":"145","author":"BERTOLI H K","year":"2019","unstructured":"Bertoli HK, Rasmussen CL, Sand FL, et al. Human papillomavirus and p16 in squamous cell carcinoma and intraepithelial neoplasia of the vagina. Int J Cancer. 2019;145(1):78\u201386.","journal-title":"Int J Cancer"},{"issue":"02","key":"27384_CR9","first-page":"163","volume":"32","author":"XH HUANG CL Z J, CHANG","year":"2016","unstructured":"Huang CL, Zhang J, Chang XH, Pang XA, Lu JX, Zhang SL. [Analysis of genotypes of human papillomavirus distribution in vaginal lesions]. Chin J Practical Gynecol Obstet. 2016;32(2):163\u2013167.","journal-title":"Chin J Practical Gynecol Obstet"},{"issue":"15","key":"27384_CR10","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.7150\/jca.20496","volume":"8","author":"P XIAO X, MENG Y B, BAI","year":"2017","unstructured":"Xiao X, Meng YB, Bai P, et al. Vulvar cancer in China: epidemiological features and risk analysis. J Cancer. 2017;8(15):2950\u20132958.","journal-title":"J Cancer"},{"key":"27384_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ygyno.2023.06.013","volume":"175","author":"E LEUNG","year":"2023","unstructured":"Leung E, Tremblay C, Liao D, et al. Treatment patterns and outcomes of patients with locally advanced vulvar or vaginal cancer in British Columbia. Gynecol Oncol. 2023;175:107\u2013113.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"27384_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","volume":"33","author":"F OONK M H M, PLANCHAMP","year":"2023","unstructured":"Oonk MHM, Planchamp F, Baldwin P, et al. European society of gynaecological oncology guidelines for the management of patients with vulvar cancer - update 2023. Int J Gynecol Cancer. 2023;33(7):1023\u20131043.","journal-title":"Int J Gynecol Cancer"},{"key":"27384_CR13","doi-asserted-by":"publisher","first-page":"109662","DOI":"10.1016\/j.radonc.2023.109662","volume":"186","author":"R NOUT","year":"2023","unstructured":"Nout R, Calaminus G, Planchamp F, et al. ESTRO\/ESGO\/SIOPe guidelines for the management of patients with vaginal cancer. Radiother Oncol. 2023;186:109662.","journal-title":"Radiother Oncol"},{"issue":"11","key":"27384_CR14","first-page":"1227","volume":"34","author":"JH ZHOU Q W X, LIU","year":"2018","unstructured":"Committee of Gynecologic Oncology, China Anti-cancer Association. [Guidelines to the diagnosis and treatment of vaginal malignant tumors. (4th edition)]. Zhongguo Shiyong Fuke Yu Chanke Zazhi. 2018;34(11):1227\u20131229.","journal-title":"Zhongguo Shiyong Fuke Yu Chanke Zazhi"},{"issue":"06","key":"27384_CR15","first-page":"533","volume":"31","author":"AC ASSOCIATION G O P C O C","year":"2021","unstructured":"Committee of Gynecologic Oncology, China Anti-cancer Association. [Diagnosis and Treatment Guidelines for Malignant Tumors of the Vulva (2021 Edition)]. China Oncol. 2021;31(06):533\u2013545.","journal-title":"China Oncol"},{"issue":"1","key":"27384_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.6004\/jnccn.2017.0008","volume":"15","author":"KOH W J","year":"2017","unstructured":"Koh WJ, Greer BE, Abu-Rustum NR, et al. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(1):92\u2013120.","journal-title":"J Natl Compr Canc Netw"},{"key":"27384_CR17","doi-asserted-by":"crossref","unstructured":"Ruffin AT, Li H, Vujanovic L, et al. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nat Rev Cancer. 2023;23(3):173\u2013188.","DOI":"10.1038\/s41568-022-00531-9"},{"key":"27384_CR18","doi-asserted-by":"crossref","unstructured":"Cillo AR, K\u00fcrten CHL, Tabib T, et al. Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer. Immunity. 2020;52(1):183\u2013199.e9.","DOI":"10.1016\/j.immuni.2019.11.014"},{"key":"27384_CR19","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang Y, Zhang Z. Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis. PLoS One. 2018;13(9):e0204162.","DOI":"10.1371\/journal.pone.0204162"},{"issue":"12","key":"27384_CR20","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1111\/aogs.14260","volume":"100","author":"RASMUSSEN C","year":"2021","unstructured":"Rasmussen CL, Bertoli HK, Sand FL, Kjaer AK, Thomsen LT, Kjaer SK. The prognostic significance of HPV, p16, and p53 protein expression in vaginal cancer: A systematic review. Acta Obstet Gynecol Scand. 2021;100(12):2144\u20132156.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"27384_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12885-023-11039-2","volume":"23","author":"T ZHANG","year":"2023","unstructured":"Zhang T, Zhu Y, Luo J, et al. An integrated model for prognosis in vulvar squamous cell carcinoma. BMC Cancer. 2023;23(1):534.","journal-title":"BMC Cancer"},{"issue":"1","key":"27384_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13027-025-00680-0","volume":"20","author":"C ZHENG Q J, WANG H H, DING","year":"2025","unstructured":"Zheng QJ, Wang HH, Ding C, et al. Clinical characteristics and prognostic impact of HPV infection in head and neck cancer patients in China: a nationwide multicenter study. Infect Agent Cancer. 2025;20(1):47.","journal-title":"Infect Agent Cancer"},{"key":"27384_CR23","unstructured":"Peng ZL, Chen AP, Liu SL, et al. [Clinicopathologyof 63 cases of vulvar malignancies and its correlation with HPV infection]. J West China Univ Med Sci. 1999;30(3):351\u2013353."},{"key":"27384_CR24","doi-asserted-by":"publisher","unstructured":"Xiong J. A study on the correlation between human papillomavirus infection and vulvar carcinoma or vaginal carcinoma [Master' thesis]. Guangzhou: Southern Medical University; 2015. https:\/\/doi.org\/10.7666\/d.Y2911128.","DOI":"10.7666\/d.Y2911128"},{"issue":"02","key":"27384_CR25","first-page":"145","volume":"14","author":"Q L.","year":"2012","unstructured":"Li Q. [Relationship between human papillomavirus, p16 and vulval cancer]. J Hebei United Univ (Health Sciences). 2012;14(02):145\u2013146.","journal-title":"J Hebei United Univ (Health Sciences)"},{"issue":"1","key":"27384_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ijgo.13880","volume":"155","author":"J OLAWAIYE A B, COTLER","year":"2021","unstructured":"Olawaiye AB, Cotler J, Cuello MA, et al. FIGO staging for carcinoma of the vulva: 2021 revision. Int J Gynaecol Obstet. 2021;155(1):43\u201347.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"27384_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.0.CO;2-6","volume":"83","author":"HR CREASMAN W T, PHILLIPS J L, MENCK","year":"1998","unstructured":"Creasman WT, Phillips JL, Menck HR. The national cancer data base report on cancer of the vagina. Cancer. 1998;83(5):1033\u20131040.","journal-title":"Cancer"},{"issue":"03","key":"27384_CR28","first-page":"264","volume":"32","author":"JIA HQ W C","year":"2016","unstructured":"Jia HQ, Wang CY. [Prognostic analysis of 82 cases of vulvar carcinoma]. Zhongguo Shiyong Fuke Yu Chanke Zazhi. 2016;32(3):264\u2013267.","journal-title":"Zhongguo Shiyong Fuke Yu Chanke Zazhi"},{"key":"27384_CR29","doi-asserted-by":"crossref","unstructured":"Lin TA, Garden AS, Elhalawani H, et al. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Cancer. 2019;125(9):1536\u20131546.","DOI":"10.1002\/cncr.31944"},{"key":"27384_CR30","doi-asserted-by":"crossref","unstructured":"Zhu G, Amin N, Herberg ME, et al. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers. JAMA Otolaryngol Head Neck Surg. 2022;148(1):70\u201379.","DOI":"10.1001\/jamaoto.2021.3228"},{"issue":"7","key":"27384_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jnci\/djaa209","volume":"113","author":"C DEHLENDORFF","year":"2021","unstructured":"Dehlendorff C, Baandrup L, Kjaer SK. Real-world effectiveness of human papillomavirus vaccination against vulvovaginal high-grade precancerous lesions and cancers. J Natl Cancer Inst. 2021;113(7):869\u2013874.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27384-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27384-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27384-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:15:49Z","timestamp":1780964149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27384-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27384"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27384-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8715679\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval No.: NCC 20\/041 2237). All procedures were performed in accordance with the relevant guidelines. Written informed consent was obtained from all participating patients during routine follow-ups. For deceased or unreachable patients, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1831"}}